Are we underestimating the potential of neuroactive drugs to augment neuromotor function in sarcopenia?

Attention Please! Unravelling the link between brain network connectivity and cognitive attention following acquired brain injury: a systematic review of structural and functional measures

Excitatory drive to spinal motoneurones is necessary for serotonin to modulate motoneurone excitability via 5-HT2 receptors in humans

Serotonergic and noradrenergic contributions to motor cortical and spinal motoneuronal excitability in humans

Muscle responses to motor cortical stimulation: Can we get more out of surface electromyography?

Enhanced availability of serotonin limits muscle activation during high-intensity, but not low-intensity, fatiguing contractions

Persistent inward currents in spinal motoneurones: how can we study them in human participants?

5‐HT2 receptor antagonism reduces human motoneuron output to antidromic activation but not to stimulation of corticospinal axons

Physiological tremor is suppressed and force steadiness is enhanced with increased availability of serotonin regardless of muscle fatigue

Human corticospinal-motoneuronal output is reduced with 5-HT₂ receptor antagonism

Enhanced serotonin availability amplifies fatigue perception and modulates the TMS‐induced silent period during sustained low‐intensity elbow flexions

Antagonism of the D2 dopamine receptor enhances tremor but reduces voluntary muscle activation in humans